十一月 2025
- Home
- ABIOMED
十一月 2025的ABIOMED市场份额分析
Abiomed, Inc. is a medical device technology company that operates as a stand-alone business within Johnson & Johnson's MedTech Segment. Abiomed develops and manufactures temporary external and implantable mechanical circulatory support devices.
ABIOMED(包含公司地区分支机构)
查看更多网站流量和参与度信息- abiomed.com
ABIOMED收入截至 十一月 2025为 > 1B
ABIOMED主要域名产生的收入
3 年中ABIOMED主要域名的收入
ABIOMED主要域名的收入
ABIOMED热门域名的总访问量
了解ABIOMED市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
ABIOMED热门域名的平均访问时长
分析ABIOMED参与度指标。
过去 3 个月的平均访问时长
子公司明细
ABIOMED热门域名的平均页面浏览量
了解ABIOMED如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
ABIOMED 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Norton Healthcare Provider partners with Abiomed, Inc..After discussion with its surgical, VAD, and Congenital Heart Failure teams, Norton Healthcare Provider worked with Abiomed to acquire the relatively new Impella RP Flex that was placed percutaneously to support the right ventricle.
七月 21, 2025阅读更多
新闻Jnjmedtech acquired Abiomed, Inc. for $16.6B on Dec 31st '22.J&J acquired the heart pump maker Abiomed in a deal worth $16.6 billion at the end of 2022.
一月 22, 2025阅读更多
新闻Johnson & Johnson acquired Abiomed, Inc. for $16B on Jan 1st '22.With the addition of V-Wave, J&J continues to build its cardiovascular device portfolio, after spending $16.6 billion to acquire Abiomed in 2022 and $13.1 billion to purchase Shockwave Medical earlier this year.
八月 20, 2024阅读更多
查看 ABIOMED 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。